Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

CompanyDrug

SSY Group Secures NMPA Approval for Nimodipine Oral Solution – Bulk Drug‑to‑Formulation Vertical Integration Strengthens Cerebrovascular Portfolio

SSY Group Limited (HKG: 2005) announced that the Group has received drug production and registration approval from China's National Medical Products Administration (NMPA) for Nimodipine Oral Solution (10 ml: 60…

Novartis' Rhapsido (Remibrutinib) Wins FDA Approval – First‑in‑Class BTK Inhibitor Becomes First Approved Treatment for Symptomatic Dermographism

Novartis’ Rhapsido (Remibrutinib) Wins FDA Approval – First‑in‑Class BTK Inhibitor Becomes First Approved Treatment for Symptomatic Dermographism

Pfizer's TUKYSA Wins FDA Approval for First‑Line Maintenance in HER2+ Metastatic Breast Cancer – Chemotherapy‑Free Tucatinib Combination Delivers 36% Reduction in Progression Risk

Pfizer’s TUKYSA Wins FDA Approval for First‑Line Maintenance in HER2+ Metastatic Breast Cancer – Chemotherapy‑Free Tucatinib Combination Delivers 36% Reduction in Progression Risk

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of mRNA Vaccine SYS6026
CompanyDrug

CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of mRNA Vaccine SYS6026

Frontera Therapeutics Receives FDA Approval for Phase II Study of FT-003 in nAMD
CompanyDrug

Frontera Therapeutics Receives FDA Approval for Phase II Study of FT-003 in nAMD

Jiangsu Kanion Pharmaceutical Gets FDA Approval to Test KYS202004A for Psoriasis
CompanyDrug

Jiangsu Kanion Pharmaceutical Gets FDA Approval to Test KYS202004A for Psoriasis

Jiangsu Hengrui Medicine Receives NMPA Clearance for Multiple Clinical Trials of Oncology Drugs
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Clearance for Multiple Clinical Trials of Oncology Drugs

Sichuan Biokin Pharmaceutical Gets FDA Approval for Phase I Study of BL-M17D1 in Solid Tumors
CompanyDrug

Sichuan Biokin Pharmaceutical Gets FDA Approval for Phase I Study of BL-M17D1 in Solid Tumors

Sichuan Huiyu Pharmaceutical's HYP-6589 Receives NMPA Approval for Solid Tumor Clinical Trial
CompanyDrug

Sichuan Huiyu Pharmaceutical’s HYP-6589 Receives NMPA Approval for Solid Tumor Clinical Trial

Frontier Biotechnologies Inc. Gets NMPA Approval for Phase II Study of Albuvirtide as HIV Therapy
CompanyDrug

Frontier Biotechnologies Inc. Gets NMPA Approval for Phase II Study of Albuvirtide as HIV Therapy

HuidaGene Receives FDA Clinical Clearance for HG202 in Neovascular AMD Treatment
CompanyDrug

HuidaGene Receives FDA Clinical Clearance for HG202 in Neovascular AMD Treatment

Show More